The DOI matches its Crossref record.
Bias and stereotyping among research and clinical professionals: Perspectives on minority recruitment for oncology clinical trials.
Abstract
152 Background: Extensive attention has been paid in recent years to the possibility that bias among health care professionals contributes to health disparities. In its 2003 report, Unequal Treatment, the Institute of Medicine concluded that bias against racial minorities may affect communication or care offered. However, the role of bias in the context of recruitment of racial minorities in cancer clinical trials has not been explored. Therefore, we assessed clinical and research personnel’s experiences related to factors influencing recruitment of racial and ethnic minorities for cancer clinical trials. Methods: Ninety-one qualitative interviews were conducted at 5 U.S. cancer centers among 4 stakeholder groups: cancer center leaders, principal investigators, referring clinicians and research staff. Data analysis was conducted using a content analysis approach to generate themes from the transcribed interviews. Results: Five prominent themes emerged. 1) Recruitment interactions with potential minority participants were perceived to be challenging. 2) Potential minority participants were not perceived to be ideal study candidates. 3) A combination of clinic level barriers and negative perceptions of minority study participants led to providers withholding clinical trial opportunities from potential minority participants. 4) When clinical trial recruitment practices were tailored to minority patients, addressing research misconceptions to build trust was a common strategy. 5) For some respondents, race was perceived as irrelevant when screening and recruiting potential minority participants for clinical trials. Conclusions: Not only did some respondents view racial and ethnic minorities as less promising participants, some respondents reported withholding trial opportunities to minorities based on these perceptions. Some providers endorsed using tailored recruitment strategies while others eschewed race as a factor in trial recruitment. The presence of bias and stereotyping among clinical and research professionals recruiting for cancer clinical trials, should be considered when designing interventions to increase minority enrollment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Fourteen included studies reported on why certain patients may have been overlooked for clinical trial participation.
“Fourteen studies reported on why certain patients may have been overlooked for clinical trial participation [12, 17, 38, 42, 44, 45, 52–55, 59, 63, 66, 69].”
From Enablers and barriers of clinical trial participation in adult patients from minority ethnic groups: a systematic review (2025) · cites this paper as [53]
These assumptions might stem from healthcare workers' prior experiences, a lack of confidence in referring patients to clinical trials, or perception of who would make appropriate candidates.
“It was suggested that these assumptions might stem from healthcare workers’ prior experiences, a lack of confidence in referring patients to clinical trials, or perception of who would make “appropriate candidates” [53, 66].”
From Enablers and barriers of clinical trial participation in adult patients from minority ethnic groups: a systematic review (2025) · cites this paper as [53]
Citations
Cited by
Sorted by citations
Enhancing Diversity and Inclusion in Clinical Trials
Corneli, A. L., Hanlen‐Rosado, E., McKenna, K., Araojo, R., Corbett, D., Vasisht, K. P., Siddiqi, B., Johnson, T., Clark, L. T., & Calvert, S. B. (2023) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2819 · Cited by 64
Passmore, S. R., Kisicki, A., Gilmore‐Bykovskyi, A. L., Green‐Harris, G., & Edwards, D. F. (2021) · Journal of Clinical and Translational Science · doi:10.1017/cts.2021.876 · Cited by 61
Alarcón Garavito, G. A., Gilchrist, K., Ciurtin, C., Khanna, S., Chambers, P., McNally, N., Merivale, E., Carr, E., Yu, R., & Vindrola-Padros, C. (2025) · Trials · doi:10.1186/s13063-025-08769-y · Cited by 42
Eche, I. J., Yusufov, M., Isibor, D. A., & Wolfe, J. (2021) · Pediatric Blood & Cancer · doi:10.1002/pbc.29328 · Cited by 31
In pursuit of equity in cancer care: Moving beyond the Affordable Care Act
Dee, E. C., Pierce, L. J., Winkfield, K. M., & Lam, M. B. (2022) · Cancer · doi:10.1002/cncr.34346 · Cited by 31
Barry, D., Steinberg, J. R., Towner, M., Barber, E. L., Simon, M. A., & Roque, D. R. (2022) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000765 · Cited by 27
The Role of Safety-Net Hospitals in Reducing Disparities in Breast Cancer Care
Crown, A., Ramiah, K., Siegel, B., et al. (2022) · Annals of Surgical Oncology · doi:10.1245/s10434-022-11576-3 · Cited by 21
Barnell, E. K., Kang, Y., Barnell, A. R., Kruse, K. R., Fiske, J., Pittz, Z. R., Khan, A., Huebner, T. A., Holmes, F. L., Griffith, M., et al. (2021) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000360 · Cited by 17
Reviewing the progress of cancer research in the USA
Okoduwa, I. O., Ashiwaju, B. I., Ogugua, J. O., et al. (2024) · World Journal of Biology Pharmacy and Health Sciences · doi:10.30574/wjbphs.2024.17.2.0046 · Cited by 11
Passmore, S. R., Edwards, D. F., Sorkness, C. A., Esmond, S. L., & Brasier, A. R. (2020) · Journal of Clinical and Translational Science · doi:10.1017/cts.2020.554 · Cited by 11
The Potential for Pragmatic Trials to Reduce Racial and Ethnic Disparities in Kidney Disease
Dember, L. M. (2022) · Journal of the American Society of Nephrology · doi:10.1681/asn.2022030301 · Cited by 9
Representation of Black patients in heart failure clinical trials
Azam, T. U., & Colvin, M. M. (2021) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000849 · Cited by 9
Challenges in Recruitment and Retention
Coffin, T. B., & Kenner, B. J. (2022) · Pancreas · doi:10.1097/mpa.0000000000002162 · Cited by 6
Passmore, S. R., Gerbitz, A., Hancock, G. R., Evans, L., Green‐Harris, G., Edwards, D. F., Jackson, T., & Thomas, S. B. (2024) · Journal of Empirical Research on Human Research Ethics · doi:10.1177/15562646231222665 · Cited by 6
Wippold, G. M., Crichlow, Z. R., Garcia, K. A., Domlyn, A. M., Sanchez, S. B., Frank, L., Mote, T., Frary, S. G., & Woods, T. (2024) · Implementation Science Communications · doi:10.1186/s43058-024-00584-x · Cited by 5
Disparities in Clinical Care and Research in Renal Cell Carcinoma
Pain, D., Takvorian, S. U., & Narayan, V. (2022) · Kidney Cancer · doi:10.3233/kca-220006 · Cited by 5
Turner, L., Taylor, S., Ward, A., Thistlethwaite, F. C., & Yorke, J. (2024) · Cancer Nursing · doi:10.1097/ncc.0000000000001399 · Cited by 5
González-Moreno, J., Agustí, A. I., Saiz, J. G., et al. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1436930 · Cited by 3
How to set up a clinical research center in Brazil, as an example of a middle-income country
Ribeiro, E. F. O., Belmiro, A. A. M. D. L. M., Boas, L. C. V., & Niemann, C. U. (2023) · Seminars in Hematology · doi:10.1053/j.seminhematol.2023.08.004 · Cited by 3
Addressing Racial Inequity in Cancer Care: Self-Awareness Among Oncology Professionals
Sweetenham, J. W. (2022) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2022.0056 · Cited by 1
Advancing Equity in Cancer Research: Opportunities for Sponsors, Institutions, and Investigators
Barrett, N. J., Bethea, K., Boehmer, L., Johnson, K. S., & Carrizosa, D. R. (2024) · North Carolina Medical Journal · doi:10.18043/001c.91423 · Cited by 1
Clinical Trial Access in Diverse Populations
Montaque, T., & Stewart, J. H. (2024) · Journal of Surgical Oncology · doi:10.1002/jso.28010 · Cited by 2
Metadata
- Authors
- Niranjan, S. J., Martin, M. Y., Fouad, M. N., Vickers, S. M., Wenzel, J., Cook, E. D., Konety, B. R., & Durant, R. W.
- Affiliations
- University of Alabama at Birmingham (US)
- University of Tennessee Health Science Center (US)
- Johns Hopkins University (US)
- The University of Texas MD Anderson Cancer Center (US)
- University of Minnesota (US)
- ORCID
- Venue
- Journal of Clinical Oncology
- Published
- 2019-09-20
- Volume
- 37
- Issue
- 27_suppl
- Pages
- 152-152
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2980473488
- Cited by
- 22
- References
- 0
- Citations by year
- 2025: 2 · 2024: 6 · 2023: 2 · 2022: 7 · 2021: 4 · 2020: 1
- Type
- conference abstract
- Language
- en
- Open access
- closed
- Locations
- Journal of Clinical Oncology (publishedVersion)
- Funders
- U.S. National Institutes of Health.
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ethics in Clinical Research
- Social Sciences › Anthropology › Race, Genetics, and Society
- Social Sciences › Gender Studies › Diversity and Career in Medicine
- Keywords
- racial and ethnic minorities, cancer clinical trials, clinical trial recruitment, stereotyping, health disparities, minority enrollment, trust building, barriers to participation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review